Back to Market Feed

GLIPIZIDE-METFORMIN 2.5-250 MG

Glipizide and Metformin HCl
$0.2671per EA

Strength

2.5; 250 mg/1; mg/1

NDC

23155011501

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

4/22/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA078728

On Market Since

6/29/2010

Pharmacological Classes

Biguanide
Biguanides
Sulfonylurea Compounds
Sulfonylurea

Price History

1W

0.0%

1M

+8.5%

3M

+37.1%

6M

+36.9%

1Y

-3.6%

3Y

-7.3%

5Y

-15.5%

All

-30.3%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

METFORMIN HCL 500 MG TABLET
Generic
00378718505•Mylan Pharmaceuticals Inc.
$0.0139
per EA
METFORMIN HCL 500 MG TABLET
Generic
00904716261•Major Pharmaceuticals
$0.0139
per EA
METFORMIN HCL 500 MG TABLET
Generic
23155084101•Heritage Pharmaceuticals Inc.
$0.0139
per EA
METFORMIN HCL 500 MG TABLET
Generic
23155084105•Heritage Pharmaceuticals Inc.
$0.0139
per EA
METFORMIN HCL 500 MG TABLET
Generic
23155084110•Heritage Pharmaceuticals Inc.
$0.0139
per EA
METFORMIN HCL 500 MG TABLET
Generic
42385094701•Laurus Labs Limited
$0.0139
per EA
METFORMIN HCL 500 MG TABLET
Generic
42385094705•Laurus Labs Limited
$0.0139
per EA
METFORMIN HCL 500 MG TABLET
Generic
42385094711•Laurus Labs Limited
$0.0139
per EA
METFORMIN HCL 500 MG TABLET
Generic
49483062201•Time-Cap Labs Inc.
$0.0139
per EA
METFORMIN HCL 500 MG TABLET
Generic
49483062210•Time-Cap Labs Inc.
$0.0139
per EA